Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
Open Access
- 1 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (10), 2978-2982
- https://doi.org/10.1038/s41375-021-01333-y
Abstract
No abstract availableFunding Information
- Stichting Kinderen Kankervrij (KiKa-264)
- Fondation ARC pour la Recherche sur le Cancer (ERA-NET TRANSCAN EJC)
- Oesterreichische Nationalbank (OeNB 18281)
- Polpharma Scientific Foundation (4/19/IX/1)
- vzw Kinderkankerfonds
- Deutsche Forschungsgemeinschaft (BE6555/2-1, BE6555/1-1, BE6555/2-1)
This publication has 15 references indexed in Scilit:
- Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemiaBlood Advances, 2020
- Cryptic recurrent ACIN1‐NUTM1 fusions in non‐KMT2A‐rearranged infant acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 2019
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized StudyJournal of Clinical Oncology, 2019
- NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2Haematologica, 2019
- PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaNature Genetics, 2019
- Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 casesProceedings of the National Academy of Sciences of the United States of America, 2018
- Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaNature Communications, 2016
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemiasNature Genetics, 2015
- Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangementsLeukemia, 2013
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007